Compile Data Set for Download or QSAR
maximum 50k data
Found 840 Enz. Inhib. hit(s) with Target = 'Diacylglycerol kinase zeta'
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594321(US11584747, Example 116 | US11584747, Example 117)
Affinity DataIC50:  2nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594236(US11584747, Example 30 | US11584747, Example 31)
Affinity DataIC50:  4nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594506(US11584747, Example 313 | US11584747, Example 314)
Affinity DataIC50:  4nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594504(US11584747, Example 311 | US11584747, Example 312)
Affinity DataIC50:  6nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50541816(CHEMBL4633304)
Affinity DataIC50:  9.60nMAssay Description:Inhibition of DGKA/DGKZ in human CD8 cells assessed as induction of CD8 activation by measuring IFNgamma level after 20 hrs by AlphaLISA assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615842(US20230271954, Compound 141 | trans-8-((-4-((cyclo...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594234(US11584747, Example 28 | US11584747, Example 29)
Affinity DataIC50:  10nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615861(US20230271954, Compound 160 | cis-8-((-4-((cyclobu...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615862(US20230271954, Compound 161 | cis-8-((-4-((cyclobu...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615864(US20230271954, Compound 163 | cis-8-((-4-(((1,4-di...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615878(US20230271954, Compound 177 | cis-8-((4-(((1,4-dio...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615902(US20230271954, Compound 201 | cis-8-((-4-((4-fluor...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615904(US20230271954, Compound 203 | cis-8-((-4-(((1,4-di...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615711(US20230271954, Compound 10 | cis-6-chloro-4-((4-(c...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615717(US20230271954, Compound 16 | cis-6-chloro-4-((4-(c...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615731(US20230271954, Compound 30 | cis-8-((4-((cycloprop...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615736(US20230271954, Compound 35 | cis-8-((4-((4-chlorop...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615743(US20230271954, Compound 42 | cis-8-((-4-((cyclobut...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615744(US20230271954, Compound 43 | cis-8-((-4-((cyclobut...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615750(US20230271954, Compound 49 | cis-8-((4-(cyclopropy...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615751(US20230271954, Compound 50 | cis-8-((4-(cyclopropy...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615752(US20230271954, Compound 51 | cis-6-chloro-4-((4-(c...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615753(US20230271954, Compound 52 | cis-8-((-4-((4-fluoro...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615756(US20230271954, Compound 55 | cis-8-((4-((4-fluorop...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615758(US20230271954, Compound 57 | US20230271954, Compou...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615764(Cis-8-4-((cyclopropylmethyl)(3,4-difluorophenyl) a...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615769(US20230271954, Compound 68 | cis-8-4-((4-fluorophe...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615786(US20230271954, Compound 85 | trans-6-chloro-4-4-((...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615792(US20230271954, Compound 91 | cis-8-4-((cyclobutylm...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615797(US20230271954, Compound 96 | trans-6-chloro-4-((cy...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615798(US20230271954, Compound 97 | cis-8-4-(benzo[d][1,3...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615800(US20230271954, Compound 99 | cis-8-4-((cyclobutylm...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615801(US20230271954, Compound 100 | cis-8-4-((cyclobutyl...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615803(US20230271954, Compound 102 | cis-8-4-((cyclopropy...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615817(US20230271954, Compound 116 | cis-8-((-4-(benzo[d]...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615833(US20230271954, Compound 132 | trans-4-((-4-(benzo[...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615672(US20230271954, Compound 3A | trans-6-chloro-4-((4-...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615673(US20230271954, Compound 3B | trans-6-chloro-4-((4-...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM615844(US20230271954, Compound 143 | cis-8-((-4-(benzo[d]...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594262(US11584747, Example 56 | US11584747, Example 57)
Affinity DataIC50:  11nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594396(US11584747, Example 196 | US11584747, Example 197)
Affinity DataIC50:  12nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594430(US11584747, Example 232 | US11584747, Example 233)
Affinity DataIC50:  13nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594400(US11584747, Example 200 | US11584747, Example 201)
Affinity DataIC50:  13nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594497(US11584747, Example 304 | US11584747, Example 305)
Affinity DataIC50:  14nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594283(US11584747, Example 77 | US11584747, Example 78)
Affinity DataIC50:  14nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594275(US11584747, Example 69 | US11584747, Example 70)
Affinity DataIC50:  14nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594323(US11584747, Example 118 | US11584747, Example 119)
Affinity DataIC50:  16nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594421(US11584747, Example 222 | US11584747, Example 223)
Affinity DataIC50:  17nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594222(US11584747, Example 16 | US11584747, Example 17 | ...)
Affinity DataIC50:  17nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM594457(US11584747, Example 261)
Affinity DataIC50:  17nMAssay Description:The reactions were carried out in 50 mM MOPS pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 μM CaCl2, and 1 mM DTT (assay buffer). The reactions using a de...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 840 total ) | Next | Last >>
Jump to: